Joshua T. Brumm - Jan 29, 2024 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
CEO & President, Director
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Stock symbol
DYN
Transactions as of
Jan 29, 2024
Transactions value $
$0
Form type
4
Date filed
1/31/2024, 04:18 PM
Previous filing
Jan 4, 2024
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Gift $0 -20K -3.42% $0.00 565K Jan 29, 2024 Direct F1, F2
transaction DYN Common Stock Gift $0 -1.5K -0.27% $0.00 563K Jan 29, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a charitable donation to a third party effective January 29, 2024 in which no value was received in return.
F2 Includes 552,729 unvested RSUs.